Functional iKIR do not consistently modify detrimental genotypes. by Laura Mora-Bitria (20477525)

“…In the corresponding permutation test the p-value becomes even less significant (P <b>=</b> 0.19). We conclude that there is no evidence that detrimental class II drivers are modified by functional iKIR.…”

Image_3_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

“…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”

Image_4_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

“…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”

Image_1_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

“…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”

Image_2_RETRACTED: Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.TIF by Zi-Xuan Wang (134651)

“…Hepatic infiltration of inflammatory cells and collagen deposition area were significantly decreased in HFD group by LOLA treatment. …”

DataSheet1_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

“…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”

DataSheet2_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

“…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”

DataSheet3_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

“…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”

Enrollment and randomization. by Helene Høgsdal (21161981)

“…No significant findings were found in the intention-to-treat analyses, but the results from per-protocol analyses showed a decrease in hyperactivity problems among the adolescents that had used the app (<i>F</i>(4,1585) = 2.89, <i>p</i> =.021). …”

Descriptive Statistics at Baseline. by Helene Høgsdal (21161981)

“…No significant findings were found in the intention-to-treat analyses, but the results from per-protocol analyses showed a decrease in hyperactivity problems among the adolescents that had used the app (<i>F</i>(4,1585) = 2.89, <i>p</i> =.021). …”

Scores vs Skip ratios on single-agent task. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Time(s) and GFLOPs savings of single-agent tasks. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

The source code of LazyAct. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Win rate vs Skip ratios on multi-agents tasks. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Visualization on SMAC-25m based on <i>LazyAct</i>. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Single agent and multi-agents tasks for <i>LazyAct</i>. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Network architectures for multi-agents task. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

<b>Data used for analyses in the manuscript 'Sleep Regularity and Duration are Associated with Depression Severity in a Nationally Representative United States Sample'</b> by Katherine Maki (7445153)

“…</p><p dir="ltr"><b>Results: </b>Among participants (n=7297), we found associations between sleep-associated variables and SRI, with increased daytime sleep being the strongest correlate of decreased SRI. …”

Loss of parasympathetic cholinergic neurons innervating the liver. by Jiyeon Hwang (19747297)

“…(E, F) Summary plots showing a significant decrease in hepatic (control, <i>n</i> = 7 mice; experimental mice, <i>n</i> = 6 mice), but not plasma (control, <i>n</i> = 11 mice; experimental mice, <i>n</i> = 8 mice), ACh contents in ChAT^{Cre + AAVrg-FLEX-dtA} mice compared to the controls. …”

Table 1_Filtered and unfiltered lipoaspirates reveal novel molecular insights and therapeutic potential for osteoarthritis treatment: a preclinical in vitro study.docx by Alissa Behn (20793590)

“…Introduction<p>Orthobiologics, such as autologous nanofat, are emerging as a potential treatment option for osteoarthritis (OA), a common degenerative joint causing pain and disability in the elderly. …”